Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, Su Z, Zhang C, Liu X, Xu G, Zhang HT. · 2018
Read Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer. by Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, Su Z, Zhang C, Liu X, Xu G, Zhang HT. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6161470.txt.
Introduction
Wang and co-authors present a research article in Molecular Cancer on a circular RNA that slows lung cancer spread. Non-small cell lung cancer often spreads when tumor cells change state, a shift called epithelial-mesenchymal transition. The growth factor TGF-beta can trigger that shift. Circular RNAs are a newer class of regulatory RNAs in cancer.
The team studied one circular RNA, circPTK2, in this cancer. It restrains the transition and the spread that follows. It works by controlling TIF1gamma, a regulator of TGF-beta signaling. Tumors with more circPTK2 were less metastatic in their data. The authors present circPTK2 as a tumor suppressor. The axis it forms with TIF1gamma may offer a new treatment angle.
Catalog record
| CREATOR | Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, Su Z, Zhang C, Liu X, Xu G, Zhang HT. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 91 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer By Longqiang Wang, Xin Tong, Zhengyu Zhou, Shengjie Wang, Zhe Lei, Tianze Zhang, Zeyi Liu, Yuanyuan Zeng, Chang Li, Jun Zhao, Zhiyue Su, Cuijuan Zhang Published in: Molecular Cancer DOI: 10.1186/s12943-018-0889-7 ABSTRACT Abstract Background TGF-β promotes tumor invasion and metastasis through inducing epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC). Circular RNAs (circRNAs) are recognized as functional non-coding RNAs involved in human cancers. However, whether and how circRNAs contribute to TGF-β-induced EMT and metastasis in NSCLC remain vague. Here, we investigated the regulation and function of Circular RNA hsa_circ_0008305 (circPTK2) in TGF-β-induced EMT and tumor metastasis, as well as a link between circPTK2 and transcriptional intermediary factor 1 γ (TIF1γ) in NSCLC. Methods Circular RNAs were determined by human circRNA Array analysis, real-time quantitative reverse transcriptase PCR and northern blot. Luciferase reporter, RNA-binding protein immunoprecipitation (RIP), RNA pull-down and fluorescence in situ hybridization (FISH) assays were employed to test the interaction between circPTK2 and miR-429/miR-200b-3p. Ectopic overexpression and siRNA-mediated knockdown of circPTK2, TGF-β-induced EMT, Transwell migration and invasion in vitro, and in vivo experiment of metastasis were used to evaluate the function of circPTK2. Transcription and prognosis analyses were done in public databases. Results CircPTK2 and TIF1γ were significantly down-regulated in NSCLC cells undergoing EMT induced by TGF-β. CircPTK2 overexpression augmented TIF1γ expression, inhibited TGF-β-induced EMT and NSCLC cell invasion, whereas circPTK2 knockdown had the opposite effects. CircPTK2 functions as a sponge of miR-429/miR-200b-3p, and miR-429/miR-200b-3p promote TGF-β-induced EMT and NSCLC cell invasion by targeting TIF1γ. CircPTK2 overexpression inhibited the invasion-promoting phenotype of endogenous miR-429/miR-200b-3p in NSCLC cells in response to TGF-β. CircPTK2 overexpression significantly decreased the expression of Snail, an important downstream transcriptional activator of TGF-β/Smad signaling. In an in vivo experiment of metastasis, circPTK2 overexpression suppressed NSCLC cell metastasis. Moreover, circPTK2 expression was dramatically down-regulated and positively correlated with TIF1γ expression in human NSCLC tissues. Especially, circPTK2 was significantly lower in metastatic NSCLC tissues than non-metastatic counterparts. Conclusion Our findings show that circPTK2 (hsa_circ_0008305) inhibits TGF-β-induced EMT and metastasis by controlling TIF1γ in NSCLC, revealing a novel mechanism by which circRNA regulates TGF-β-induced EMT and tumor metastasis, and suggesting that circPTK2 overexpression could provide a therapeutic strategy for advanced NSCLC. Electronic supplementary material The online version of this article (10.1186/s12943-018-0889-7) contains supplementary material, which is available to authorized users. Keywords: NSCLC, CircPTK2, TIF1γ, EMT, miR-429/miR-200b-3p BACKGROUND Lung cancer is the leading cause of cancer-related deaths worldwide, and ~ 85% of all lung cancers are non-small cell lung cancer (NSCLC) [1, 2]. Despite improvement in therapeutic strategies, NSCLC patients yet exhibits poor prognosis [3]. This is predominantly attributed to tumor metastasis [4], suggesting that elucidation of the mechanisms underlying NSCLC metastasis is becoming a big challenge. Transforming growth factor β (TGF-β) is highly expressed in NSCLCs [5–7]. Our previous study showed that TGF-β can promote epithelial-mesenchymal transition (EMT) and NSCLC cell invasion [8, 9]. In fact, there are compelling data that TGF-β/Smad signaling potently contributes to EMT and tumor metastasis in various human cancers [10, 11]. Recently, we have provided evidence that repression of transcriptional intermediary factor 1 γ (TIF1γ), a regulator of TGF-β/Smad signaling [12, 13], enhanced TGF-β-induced EMT in NSCLC cells [14]. In support of this, TIF1γ exerts its repressive activity on TGF-β/Smad signaling and plays an antagonistic role in TGF-β-induced EMT in mammary epithelial cells [11, 15, 16]. These data strongly suggest that TIF1γ functions as a tumor metastasis suppressor in human cancers, including NSCLC, by inhibiting TGF-β-induced EMT. CircRNAs, a class of non-coding RNAs, are involved in gene regulation at both transcriptional and post-transcriptional levels [17]. Most of circRNAs are derived from a single exon or multiple exons and are detected in the cytoplasm [18, 19]. CircRNAs have been discovered to work as miRNA sponges [17, 20, 21]. The best-known ones so far include the recently identified circRNA, ciRS-7, which can efficiently tether miR-7, leading to reduced miR-7 activity and increased levels of oncogenic factors in cancer-associated signaling pathways [22]. Most recently, Hsiao et al. found that circCCDC66 may protect MYC mRNA from the attack of miRNA-33b and miR-93 to promote colon cancer growth and metastasis [23]; Han et al. reported that circMTO1 inhibits hepatocellular carcinoma progression by disrupting oncogenic miR-9 and promoting p21 expression [24]. However, the regulatory mechanisms of circRNAs in cancer need to be extensively validated [21]. Of more importance, hundreds of circRNAs were regulated in human mammary cells undergoing EMT [25], suggesting that certain circRNAs play important roles in TGF-β-induced EMT and thus influence cancer metastasis. RNA-binding protein Quaking (QKI) was identified to control biogenesis of > 30% of abundant circRNAs during EMT in response to TGF-β [25]. Furthermore, QKI is frequently down-regulated in NSCLC tissues and significantly associated with poorer prognosis [26]. These findings suggested that down-regulated circRNAs may be implicated in NSCLC progression, invasion and metastasis. Taken together, we hypothesized that there may be several dysregulated circRNAs affecting TIF1γ activity and thereby promoting TGF-β-induced EMT and invasion in NSCLC. To test this, we first performed Human circRNA Array analysis in NSCLC cells before and after they underwent EMT in response to TGF-β, and identified 187 differentially expressed circRNAs. From the viewpoint of prediction, we focus on a down-regulated circRNA (hsa_circ_0008305 in circBase: http://www.circbase.org) produced from the PTK2 gene, termed as circPTK2. Intriguingly, we further investigated the regulation and function of circPTK2 in TGF-β-induced EMT and tumor metastasis, as well as a link between circPTK2 and TIF1γ in NSCLC. Our findings show that circPTK2 suppresses TGF-β-induced EMT and tumor cell invasion by controlling TIF1γ in NSCLC, revealing a novel mechanism by which circRNA regulates TGF-β-induced EMT and tumor metastasis. RESULTS TIF1γ and circPTK2 are down-regulated during TGF-β-induced EMT in NSCLC cells Public data suggest that TIF1γ is a tumor suppressor in NSCLC progression (Additional file 1: Figure S1A-D). Moreover, increased expression of TGF-β has been proved in NSCLC [5–7, 27] and TIF1γ knockdown promotes TGF-β-induced EMT in NSCLC cells [14]. To investigate whether TGF-β can down-regulate TIF1γ expression in EMT, we first examined TIF1γ expression in A549 cells before and after they had undergone EMT in response to TGF-β1. The TGF-β1-treated A549 cells were steadily mesenchymal with typical morphology and maker expression (Fig. 1a). Meanwhile, TIF1γ expression was significantly reduced in TGF-β-induced EMT of A549 cells (Fig. 1a). Next, RNA from epithelial and mesenchymal A549 cells was subjected to Arraystar Human circRNA Array analysis. We found that 88 circRNAs were up-regulated and 99 circRNAs were down-regulated when comparing mesenchymal A549 cells with epithelial A549 cells (≥ 1.5-fold; P < 0.05) (Fig. 1b and Additional file 2: Table S1). Using computational algorithms based on TargetScan/miRBase and miRanda, we predicted that circPTK2 (Arraystar ID: hsa_circRNA_104703) and TIF1γ 3’-UTR harbor the binding sites for miR-429/miR-200b-3p (Additional file 3: Figure S2A-C). Therefore, we focused on circPTK2 which was down-regulated 1.6-fold in TGF-β-induced EMT (Fig. 1b and Additional file 2: Table S1), and validated the characterization of circPTK2 in A549 and H226 cells (Fig. 1c-f). To confirm the microarray result, we performed qRT-PCR analysis and found that circPTK2 expression was significantly reduced in A549 and H226 cells treated with TGF-β1 for 24 h (Fig. 1g). Moreover,